Bone marrow cell transplant for cerebral palsy from brain hypoxia
Part of Mental health clinical trials.
This trial tests whether transplanting bone marrow cells can help children with spastic cerebral palsy caused by a lack of oxygen to the brain. It may improve movement and daily function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 1 and 10 years old
- Diagnosed with spastic cerebral palsy from brain hypoxia
- Has a GMFCS level between II and V (moderate to severe movement challenges)
- No bleeding disorders, active infections, or serious health problems like heart or kidney failure
- No cancer or HIV, and not currently sick with viral hepatitis
- Hemoglobin level is at least 110 g/L (not severely anemic)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting cells from a child's own bone marrow, combined with rehabilitation therapy, can improve movement and function in young children with cerebral palsy caused by birth-related brain injury or bleeding. The goal is to see if this approach helps children move better and become more independent.
This trial gives children with brain injuries an infusion of stem cells from their own or a sibling's umbilical cord blood, or from a matched donor. The goal is to see if these cells can help repair brain damage and improve function.
This trial tests whether an infusion of human umbilical cord blood can help improve symptoms in children and teens with cerebral palsy. It is a phase 1 study, meaning the main goal is to check safety and find the right dose.
This trial tests whether an IV infusion of lab-grown stem cells from donated umbilical cord is safe for people with cerebral palsy. It mainly focuses on side effects and safety rather than proving it works.
This trial tests a special type of donor stem cell transplant (with donor T-cells removed) to treat serious non-cancer blood problems in children. It may help by resetting the bone marrow so the body can make healthy blood cells again.
This trial tests a specific type of bone marrow transplant for people with sickle cell disease (or certain other blood disorders) who have had serious complications despite standard care. It aims to see if removing the patient’s immune cells and using a matched donor’s cells can improve outcomes and reduce complications.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.